AI startups raised $104 billion in first half of year, but exits tell a different story

AI startups raised 4 billion in first half of year, but exits tell a different story


In this photo illustration, Claude AI logo is seen on a smartphone and Anthropic logo on a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Sopa Images | Lightrocket | Getty Images

OpenAI and Anthropic continue to lead a fundraising bonanza in artificial intelligence, raising historic rounds and stratospheric valuations.

But when it comes to finding AI exits for venture firms, the market looks a lot different.

AI startups raised $104.3 billion in the U.S. in the first half of this year, nearly matching the $104.4 billion total for 2024, according to PitchBook. Almost two-thirds of all U.S. venture funding went to AI, up from 49% last year, PitchBook said.

The biggest deals follow a familiar theme. OpenAI raised a record $40 billion in March in a round led by SoftBank. Meta poured $14.3 billion into Scale AI in June as part of a way to hire away CEO Alexandr Wang and a few other top staffers. OpenAI rival Anthropic raised $3.5 billion, while Safe Superintelligence, a nascent startup started by OpenAI co-founder Ilya Sutskever, raised $2 billion.

While Meta’s massive investment into Scale AI amounted to a lucrative exit of sorts for early investors, the overarching trend has been a lot more money going in than coming out.

In the first half, there were 281 VC-backed exits totaling $36 billion, according to PitchBook. That includes the roughly $700 million acquisition of EvolutionIQ, an AI platform for disability and injury claims management, by CCC Intelligent Solutions, and the public listing of Slide Insurance, which builds AI-powered insurance offerings for homeowners. Slide is valued at about $2.3 billion.

Read more CNBC reporting on AI

“The dominant exit trend right now is frequent but lower-value acquisitions and fewer IPOs with significantly higher value,” said Dimitri Zabelin, PitchBook’s senior research analyst for AI and cybersecurity.

CoreWeave’s IPO, which took place at the very end of the first quarter, was the exception on the infrastructure side. The stock shot up 340% in the second quarter, and the company is now valued at over $63 billion.

Zabelin said the pattern of more investments in applications with smaller deals has been in place for the past year.

“Vertical solutions tend to plug more easily into existing enterprise gaps,” Zabelin said.

The acquisitions wave is being driven, in part, by what Zabelin calls bolt-on deals where larger companies buy smaller startups to enhance their own future valuations, hoping to enhance their value ahead of a future sale or IPO.

“That also has to do with the current liquidity conditions in the macro environment,” Zabelin said.

Outside of AI, activity is slow. U.S. fintech funding dropped 42% in the first half of the year to $10.5 billion, according to Tracxn. Cloud software and crypto have also seen sharp pullbacks.

Zabelin said IPO activity could pick up if economic conditions improve and if interest rates come down. Investors clearly want opportunities to back promising AI companies, he said.

“The appetite for AI, specifically vertical applications, will continue to remain robust,” Zabelin said.

— CNBC’s Kevin Schmidt contributed to this report.

WATCH: Goldman Sachs’ Stephan Feldgoise on M&A landscape

Goldman Sachs' Stephan Feldgoise on M&A landscape: One of the highest $10B+ transaction years YTD



Source

U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets
World

U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets

A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 16, 2026. Jeenah Moon | Reuters Global markets are entering the week balancing resilient risk appetite against renewed geopolitical strain as prospects of U.S.-Iran negotiations took a hit over the weekend. U.S. President Donald Trump scrapped […]

Read More
Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in .75 billion deal
World

Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

SHANGHAI, CHINA – NOVEMBER 05: People visit the booth of Organon during the 7th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November 5, 2024 in Shanghai, China. The 7th China International Import Expo (CIIE) kicked off in Shanghai on November 5. (Photo by Tang Yanjun/China News Service/VCG via […]

Read More
China industrial profits jump 15.8% in March, fueled by AI and chip boom despite oil shock risks
World

China industrial profits jump 15.8% in March, fueled by AI and chip boom despite oil shock risks

Employees work on the production line of solar panels at a workshop of Jiangsu DMEGC New Energy Co., Ltd. on July 22, 2025 in Suqian, Jiangsu Province of China. Vcg | Visual China Group | Getty Images Profits at China’s industrial firms grew at their fastest pace in six months in March, even as the […]

Read More